What is largely missing is the tier that decides clinical questions: randomized, controlled, blinded human trials with objective endpoints
However, while technical limitations may exist regarding adequate GSH rescue, we cannot rule out non-canonical and non-enzymatic functions of GCLC contributing to lipid-related phenotypes
Moreover, TD contains nuclear export signal sequences that are responsible for the subcellular location of p53
Because Glow Blend combines GHK-Cu, TB-500, and BPC-157, observed responses may reflect the combined regenerative, recovery-focused, collagen-related, and physiological-resilience research profiles of these peptides
Craig: I'm hopeful that doesn't happen, but that's in the works